|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| C12N 15/113 | |||
| A61K 31/712 |
| (11) | Number of the document | 1910395 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06773838.5 |
| Date of filing the European patent application | 2006-06-23 | |
| (97) | Date of publication of the European application | 2008-04-16 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/024469 |
| Date | 2006-06-23 |
| (87) | Number | WO 2007/002390 |
| Date | 2007-01-04 |
| (30) | Number | Date | Country code |
| 693542 P | 2005-06-23 | US |
| (72) |
BAKER, Brenda, F., US
KRAINER, Adrian, R., US
HUA, Yimin, US
|
| (73) |
Isis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
COLD SPRING HARBOR LABORATORY, Box 100, One Bungtown Road, Cold Spring Harbor, NY 11724, US |
| (54) | Compositions and methods for modulation of SMN2 splicing |
| Compositions and methods for modulation of SMN2 splicing |